AstraZeneca opens two major scientific laboratories
AstraZeneca has opened two new scientific labs in the UK at its sites in Macclesfield, Cheshire and Charnwood in Leicestershire.
AstraZeneca has opened two new scientific labs in the UK at its sites in Macclesfield, Cheshire and Charnwood in Leicestershire.
Professor Dame Nancy Rothwell, vice-president for research at Manchester University, performed the official opening ceremony for the new £60m Cancer Research Area Building, at Alderley Park, Manchester.
A new biology building, costing £16m, will be officially opened by AstraZeneca ceo, David Brennan, at the company's research site in Charnwood, Loughborough, tomorrow.
The new Cancer Research Area incorporates high-tech laboratories for 265 scientists, including bioscientists, chemists, specialists involved in drug metabolism and pharmacokinetics, as well as mass spectroscopy and nuclear magnetic resonance. Their research will contribute towards the company's aim to increase candidate drug output.
The new biology building will provide capacity for up to 75 scientists, in specialist laboratory facilities, "enabling more enhanced integration of safety assessment with discovery sciences, across a range of several disease areas", the company said.
Commenting on the investments Brennan said: "Although AstraZeneca is a global company, the UK is a crucial base for two major r&d sites, at which we continue to invest in British science. Globally, we spend around $14 (£7.4) m each working day on r&d, across 11 r&d centres in seven countries. Our goal is to get life-changing medicines to patients as quickly, safely and efficiently as possible."